Efficacy of Probiotic Use in Acute Diarrhea in Children: A Meta-Analysis
Jeannie S. Huang
Children’s Hospital, Boston,
Massachusetts, USA. Harvard School of Public Health, Boston, Massachusetts,
USA
Athos Bousvaros
Children’s Hospital, Boston,
Massachusetts, USA. Harvard School of Public Health, Boston, Massachusetts,
USA
John W. Lee
Harvard School of Public Health, Boston, Massachusetts, USA
Angela Diaz
Harvard School of Public Health, Boston, Massachusetts, USA. Mount
Sinai School of Medicine, New York, New York, USA
Emily J. Davidson
Children’s Hospital, Boston,
Massachusetts, USA. Harvard School of Public Health, Boston, Massachusetts,
USA
Abstract
Our objective was to determine the efficacy of probiotic use in reducing the
duration of increased stool output in children with acute diarrheal illness.
Eligible studies were limited to trials of probiotic therapy in otherwise
healthy children <5 years old with acute-onset diarrhea. The main outcome
variable was difference in diarrhea duration between treatment and control
groups. Our meta-analysis of 18 eligible studies suggests that
coadministration of probiotics with standard rehydration therapy reduces the
duration of acute diarrhea by ~1 day [random-effects pooled estimate = -0.8
days (-1.1, -0.6), P < 0.001]. Differences in treatment effect
between studies was assessed by calculating the Q statistic (Q
= 204.1, P < 0.001). In subsequent analyses limited to studies
of hospitalized children, to double-blinded trials, and to studies
evaluating lactobacilli, the pooled estimates were similar (-0.6 to -1.2
days, P < 0.001). In conclusion, bacterial probiotic therapy
shortens the duration of acute diarrheal illness in children by
approximately one day.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.